Itzhak Krinsky Joins Halo Pharma Board of Directors

June 27, 2017
Pharmaceutical Technology Editors

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-07-05-2017, Volume 12, Issue 7

Krinsky joined the board of directors at Halo after working for Teva Pharmaceuticals for 12 years.

On June 27, 2017, Halo Pharma announced the appointment of Itzhak Krinsky, PhD, to its board of directors. Krinsky has experience in the pharmaceutical industry, investment banking, and an academic career in finance and business economics. Prior to joining Halo, Krinsky worked for Teva Pharmaceuticals for 12 years. He retired from Teva earlier in 2017. During his tenure at Teva, Krinsky served as executive vice-president of Corporate Business Development, a member of the Teva executive committee, chairman of Teva Japan, chairman of Teva South Korea, and head of Business Development Asia Pacific.

Prior to joining Teva, he held various senior positions in investment banks in New York City including with Bankers Trust, Deutsche Bank, and the Silverfern Group, Inc. Krinsky also served as a professor of Finance and Business Economics at the Michael G. DeGroote School of Business, McMaster University, Ontario, Canada. He has published more than 80 articles in peer-reviewed academic journals.

Source: Halo Pharma